Xtandi (enzalutamide) and Lanoxin (digoxin) - enzalutamide laboratory test interference leading to falsely elevated digoxin plasma levels

22/09/2025
Medicines for human use Direct healthcare professional communication (DHPC)

Important Safety Information from Astellas Pharma Europe and Aspen Pharma Trading Limited regarding Xtandi (enzalutamide) and Lanoxin (digoxin): enzalutamide laboratory test interference leading to falsely elevated digoxin plasma levels

Documents

Xtandi and Lanoxin - Direct Healthcare Professional Communication PDF : 358KB | 22/09/2025